Dow Down0.17% Nasdaq Down0.28%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
13.42 Down 0.49(3.52%) 4:00PM EDT
|After Hours : 13.42 Up 0.00 (0.03%) 4:39PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   47,114   92,773  
Cost of Revenue -   -   -  
Gross Profit -   47,114   92,773  
Operating Expenses
Research Development99,760  118,595  108,582  
Selling General and Administrative27,916  (18,673)22,719  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (127,676) (52,808) (38,528)
Income from Continuing Operations
Total Other Income/Expenses Net896  752  327  
Earnings Before Interest And Taxes(126,780)(52,056)(38,201)
Interest Expense -  1,908  1,841  
Income Before Tax(126,780)(53,964)(40,042)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(126,780)(53,964)(40,042)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (126,780) (53,964) (40,042)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (126,780) (53,964) (40,042)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.